top of page

"Tripping Away the Pain: Unveiling the Psychedelic Solution to Cluster Headaches"

Psychedelics as treatment for headaches

Cluster headaches, often described as one of the most excruciating pain experiences a person can endure, have baffled the medical community for decades. These intensely painful headache episodes, often referred to as “suicide headaches” due to the desperation they can induce, have driven researchers to explore a myriad of treatment avenues. Recently, a rather unconventional approach has surfaced, garnering attention and hope: the use of psychedelics, particularly LSD (lysergic acid diethylamide) and psilocybin (found in magic mushrooms), as potential therapeutic agents.

A Desperate Need for Answers

Cluster headaches occur in cyclical patterns or cluster periods, and they are known for their abrupt onset. Sufferers experience debilitating pain, typically on one side of the head, and may also encounter symptoms such as eye watering, nasal congestion, and facial sweating. While certain medications and treatments like oxygen therapy can provide relief for some, a significant proportion of sufferers find little to no respite from available treatments. This desperate need for effective interventions has opened the door to investigating more radical approaches, such as psychedelics.

Psychedelics: An Unlikely Hero?

Psychedelics have been employed, in various cultures and settings, to alter consciousness and perception for centuries. In recent decades, medical and scientific communities have started to peel back the layers of taboo surrounding these substances, exploring their potential therapeutic applications. For cluster headaches, both anecdotal reports and emerging scientific studies suggest that psychedelics, even in sub-hallucinogenic doses, might offer profound and sustained relief. But how?

Mechanism of Action: A Mystery Unfolding

The exact mechanisms through which psychedelics might alleviate cluster headaches remain somewhat elusive, but certain theories have gained traction. Serotonin, a neurotransmitter closely linked with mood and pain perception, is also implicated in the etiology of cluster headaches. Psychedelics, notably LSD and psilocybin, are known to modulate serotonin receptors in the brain, which may influence the frequency, duration, and intensity of headache episodes. Some researchers hypothesize that psychedelics might disrupt dysfunctional pain signaling and modulate neuroinflammation, thereby providing relief.

The Journey of Research: Findings and Hurdles

Research into psychedelics for cluster headaches is still in the early stages but has produced intriguing results. Case reports and small-scale studies have documented substantial reductions in headache frequency and intensity among sufferers who used sub-hallucinogenic doses of LSD or psilocybin. Some participants even experienced extended periods of remission, where they were entirely free from attacks.

Patient Advocacy and Policy Consideration: A Delicate Balance

Patient advocacy groups, particularly those associated with cluster headache and psychedelic research, have emerged as pivotal voices, championing for further exploration and loosening restrictions on psychedelic substances. Their pleas revolve around compassion for those suffering and an urgent call for more viable treatment options.

Final Thoughts: A Vision of Hope

The application of psychedelics in treating cluster headaches shines a light on a fascinating intersection between traditional, often stigmatized substances, and cutting-edge medical treatment. Early findings fuel hope among sufferers and researchers alike, the journey towards establishing psychedelics as a widely accepted, safe, and effective treatment for cluster headaches will hopefully become more main stream soon.


Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC.Neurotherapeutics. 2021 Jan;18(1):534-543. doi: 10.1007/s13311-020-00962-y. Epub 2020 Nov 12.PMID: 33184743 Psychedelics as preventive treatment in headache and chronic pain disorders.

Schindler EAD.Neuropharmacology. 2022 Sep 1;215:109166. doi: 10.1016/j.neuropharm.2022.109166. Epub 2022 Jun 16.PMID: 35718005

Schindler EAD.Curr Pain Headache Rep. 2023 Sep;27(9):489-495. doi: 10.1007/s11916-023-01145-y. Epub 2023 Aug 4.PMID: 37540398

Note: This article is not intended to promote self-medication or the illicit use of psychedelic substances. Some places already have decriminalized psychedelic use and so it is important to know the regulations for where you live. Always consult healthcare professionals and follow local laws and guidelines regarding substance use. Always prioritize safety and consult professionals when dealing with health-related issues.

4 views0 comments


bottom of page